Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Mollie Leoni, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback